Plasma 25-hydroxyvitamin D(3) and bladder cancer risk according to tumor stage and FGFR3 status: a mechanism-based epidemiological study.
about
Vitamin D and urological cancersDietary factors associated with bladder cancerVitamin D and the epidemiology of upper gastrointestinal cancers: a critical analysis of the current evidenceStatistical methods for studying disease subtype heterogeneityA place for precision medicine in bladder cancer: targeting the FGFRs.ARID1A alterations are associated with FGFR3-wild type, poor-prognosis, urothelial bladder tumors.1α,25(OH)2D3 differentially regulates miRNA expression in human bladder cancer cellsExpression of Vitamin D Receptor (VDR) Positively Correlates with Survival of Urothelial Bladder Cancer Patients.Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy.Association of vitamin C, vitamin D, vitamin E and risk of bladder cancer: a dose-response meta-analysis.The roles of vitamin D in seborrhoeic keratosis: possible genetic and cellular signalling mechanisms.Impact of serum vitamin D level on risk of bladder cancer: a systemic review and meta-analysis.Noninvasive approaches for detecting and monitoring bladder cancer.Bladder Cancer is Associated with Low Plasma 25-hydroxyvitamin D Concentrations in Tunisian Population.Asthma status is associated with decreased risk of aggressive urothelial bladder cancer.
P2860
Q26739735-0B74F91E-8D54-4062-9B8A-B691CB3AB0A9Q26744166-533250FF-3862-4679-9A77-2197DDF56740Q26998011-16C1574F-A391-4E32-8209-EC749F1B9E79Q28385063-9E7923B1-5CA8-4E97-9E7E-E4B67F4605B7Q30249143-B9280516-B3D5-4A51-B273-73CA7256CA93Q34708383-1FF6D442-0294-4964-B921-9B39CF53F3E9Q35181387-32C34FBA-E2A7-4124-AD67-7FC8A94AA31EQ36247407-2B45D1DF-3940-4C55-B379-AB34681C93B4Q37341453-61BFB0A0-AC35-4E59-855A-1A4FF46BC4BFQ37744327-9830713D-D984-4110-B2F7-FD8C98D3774EQ38121923-389BEE3F-4427-4107-BDE9-139F24982821Q38264095-CA3123B9-C9BF-4EEE-8A51-2256AFD591AAQ38286089-1C8023B4-6238-4B80-BDD1-E9CD8B26B119Q38901981-4AB02C2D-75B7-4E3B-9986-022A7D2988B5Q48306502-E7350CB6-172F-41A8-ABE4-B9997B9FDB4E
P2860
Plasma 25-hydroxyvitamin D(3) and bladder cancer risk according to tumor stage and FGFR3 status: a mechanism-based epidemiological study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Plasma 25-hydroxyvitamin D(3) ...... m-based epidemiological study.
@ast
Plasma 25-hydroxyvitamin D(3) ...... m-based epidemiological study.
@en
type
label
Plasma 25-hydroxyvitamin D(3) ...... m-based epidemiological study.
@ast
Plasma 25-hydroxyvitamin D(3) ...... m-based epidemiological study.
@en
prefLabel
Plasma 25-hydroxyvitamin D(3) ...... m-based epidemiological study.
@ast
Plasma 25-hydroxyvitamin D(3) ...... m-based epidemiological study.
@en
P2093
P2860
P50
P356
P1476
Plasma 25-hydroxyvitamin D(3) ...... sm-based epidemiological study
@en
P2093
Alfredo Carrato
Debra T Silverman
Josep Lloreta
Manolis Kogevinas
Manuel Rivas del Fresno
Marinela Méndez-Pertuz
Spanish Bladder Cancer/EPICURO Study investigators
Yves Allory
P2860
P304
P356
10.1093/JNCI/DJS444
P407
P577
2012-10-29T00:00:00Z